Mirzaie, Mehdi
Gholizadeh, Elham
Miettinen, Juho J. http://orcid.org/0000-0002-3987-1693
Ianevski, Filipp
Ruokoranta, Tanja
Saarela, Jani http://orcid.org/0000-0001-7306-7175
Manninen, Mikko
Miettinen, Susanna
Heckman, Caroline A. http://orcid.org/0000-0002-4324-8706
Jafari, Mohieddin http://orcid.org/0000-0002-6991-8587
Funding for this research was provided by:
Academy of Finland (332454, 320185, 334781, 357686)
Jane ja Aatos Erkon Säätiö (220031)
Sigrid Juséliuksen Säätiö
Article History
Received: 16 June 2023
Revised: 1 February 2024
Accepted: 6 February 2024
First Online: 1 March 2024
Competing interests
: C.A.H. has received research funding from BMS/Celgene, Kronos Bio, Novartis, Oncopeptides, Orion Pharma, WNTResearch, Glykos Finland, and IMI2 projects HARMONY and HARMONYPLUS, plus personal fees from Amgen and Autolus unrelated to this work. The remaining authors declare no competing interests.